Loading...
Chronic rhinosinusitis (CRS) affects about 10% of the population. Current guidelines recommend first-line therapy with a daily nasal steroid (either in a nasal spray or nasal irrigation) along with saline rinses (Int Forum Allergy Rhinol 2021; 11:213). These recommendations are based on adult studies; data on children with CRS are scant.
Researchers in Poland randomized 63 children to 12 weeks of daily mometasone nasal spray with saline mists or saline alone. CRS was diagnosed by an otolaryngologist clinically on the basis of a European position paper (i.e., nasal congestion or nasal discharge, along with either facial pain/pressure or cough, for 12 weeks or more; Rhinology 2012; 50:1). Only the nasal steroid group had an improvement in Sinu…